Patients with primary Merkel cell carcinoma are at an increased risk of developing a secondary skin cancer vs other malignancies.

Artificial intelligence models, pretrained on vast datasets, significantly outperformed a standard baseline model in ...

squamous cell skin cancer melanoma skin cancer Merkel cell skin cancer basal cell skin cancer – but it is very rare for this type of skin cancer to spread It can also be used to treat skin metastases ...

but there are other non-melanoma skin cancers. These include basal cell carcinoma, squamous cell carcinoma and, less commonly, Merkel cell carcinoma, Kaposi s sarcoma and T-cell lymphoma of the skin.

Dutch researchers have developed an AI tool that could transform how surgeons treat the most common form of cancer in the Netherlands: basal cell carcinoma ... tissue while sparing as much healthy ...

SkinJect Inc. a wholly owned subsidiary of Medicus Pharma Ltd., is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer ...

("Medicus" or the "Company") is pleased to announce a positively trending interim analysis for SKNJCT-003 Phase 2 clinical study to non-invasively treat basal cell carcinoma of the skin (BCC).The ...

SkinJect Inc. a wholly owned subsidiary of Medicus Pharma Ltd., is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using ...

SkinJect Inc. a wholly owned subsidiary of Medicus Pharma Ltd., is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using ...